期刊文献+

共聚物胶束对硝基喜树碱内酯环稳定性的影响 被引量:3

Effect of copolymer micelles on lactone stability of 9-nitro-20(S)-camptothecin
下载PDF
导出
摘要 目的评价共聚物胶束对9-硝基喜树碱(9-NC)内酯环稳定性的影响。方法采用HPLC法测定,以甲醇-PBS(70:30,pH6.5)为流动相,检测波长370 nm,流速1 ml.min-1。结果内酯和羧酸盐形式的9-NC能完全分离;在PBS(pH7.4)中培养160 min后,载药胶束中具有抗肿瘤活性的9-NC内酯比例占80%,而无胶束包覆的原料药中内酯比例仅15%。结论共聚物胶束能有效提高9-NC内酯环结构的稳定性。 OBJECTIVE To evaluate the effect of copolymer micelles on lactone stability of 9 - nitro - 20 (S) - camptothecin (9 - NC). METHODS The detection was carried out with HPLC at 370 nm ; the mobile phase was consisted of methanol and phosphate buffer solution (PBS) (70 : 30, pH6.5) with the flow rate ofl ml·min^-1.RESULTS The lactone form and carboxylate form of 9- NC could be separated completely. The linear range of two forms was 0. 2 - 10. 0 μg·ml^-1. After incubation in PBS (pH7. 4) for 160 min, 80 percent of 9 -NC in micelles were lactone form with high anticancer activity while 15 percent in free form of 9 -NC. CON- CLUSION Copolymer micelles could improve the lactone stability of 9 - NC.
出处 《华西药学杂志》 CAS CSCD 北大核心 2008年第1期1-3,共3页 West China Journal of Pharmaceutical Sciences
基金 国家重点基础研究规划项目(973)(2005CB623903)
关键词 胶束 9-硝基喜树碱 稳定性 高效液相色谱 Micelles 9 - Nitro - 20 (S) - camptothecin Stability HPLC
  • 相关文献

参考文献10

  • 1Stehlin JS, Giovanella BC, Natelson EA, et al. A study of 9-nitrocamptothecin (RFS-2000) in patients with advanced pancreatic cancer [J]. Int J Oncol, 1999, 14:821 - 831.
  • 2Verschraegen CF, Gupta E, Loyer E, et al. A phase Ⅱ study of oral 9 - nitrocamptothecin in patients with refractory epithelial ovarian, tubal or peritoneal cancer [ J ]. Anticancer Drugs, 1999, 1:375 - 383.
  • 3Cao Z, Harris N, Kozielski A, et al. Alkyl esters of camptothecin and 9 - nitrocamptothecin : synthesis, in vitro pharmacokinetics, toxicity and antitumor activity [J]. J Med Chem, 1998,41 : 31 -37.
  • 4陈军,平其能,郭健新,刘蕾,储晓筑,宋鸣梅.9-硝基喜树碱内酯型在大鼠体内外的稳定性[J].药学学报,2005,40(10):888-892. 被引量:12
  • 5Chow D, Gong L, Wolfe MD, et al. Modified lactone/carboxylate salt equilibria in vivo by liposomal delivery of 9 -nitrocamptothecin [J]. Ann NY Acad Sci, 2000, 922:164 - 174.
  • 6Knight V, Koshkina NV, Waldrep JC, et al. Anticancer effect of 9 - nitrocamptothecin liposome aerosol on human cancer xenografts in nude mice [ J]. Cancer Chemother Pharmacol, 1999, 44:177-186.
  • 7Kumaresh SS, Tejraj MA, Anandrao RK, et al. Biodegradable polymeric nanoparticles as drug delivery devices [ J ]. J Control Rel, 2001, 70:1 -20.
  • 8Allen C, Maysinger D, Eisenberg A. Nano - engineering block copolymer aggregates for drug delivery [ J ]. Colloids Surf B, 1999, 16:3-27.
  • 9Lavasanifar A, Samuel J, Kwon GS. Micelles self - assembled from poly ( ethylene oxide) - block - poly ( N - hexyl stearate L - aspartamide) by a solvent evaporation method: effect on the solubilization and haemolytic activity of amphotericin B [ J]. J Contr Rel, 2001, 77:155 -160.
  • 10陈军,平其能,郭健新,丁明港.脂质体对9-硝基喜树碱内酯型和羧酸盐型体外平衡的影响[J].中国药科大学学报,2005,36(4):316-320. 被引量:18

二级参考文献22

  • 1潘显道,王存英.天然抗肿瘤药喜树碱衍生物的研究进展[J].药学学报,2003,38(9):715-720. 被引量:31
  • 2周卫,平其能,王丽杰.羟喜树碱脂质体的粒径对组织分布的影响[J].中国药科大学学报,2005,36(2):125-128. 被引量:15
  • 3Hertzberg RP, Caranfa M J, Holden KG, et al.Modification of the hydroxy lactone ring of camptothecin:inhibition of mammalian topoisomerase Ⅰ and biological activity [ J]. J Med Chem, 1989,32(3) :715 - 720.
  • 4Burke TG, MI Z. The structure basis of camptothecin interactions with human serum albumin: impact on drug stability [J]. J Med Chem, 1994,37( 1 ) :40 -46.
  • 5Zhong DF, Li K, Xu JH, et al. Pharmacokinetics of 9-nitro-20 (S) -camptothecin in rats [ J ]. Acta Pharmacol Sin, 2003,24( 3 ) :256 - 262.
  • 6Loos W J, Sparreboom A, Verweij J, et al. Determination of the lactone and lactone plus carboxylate forms of 9-aminocamptothecin in human plasma by sensitive highperformance liquid chromatography with fluorescence detection [ J ]. J Chromatogr B, 1997,694:435 - 441.
  • 7Cao Z, Harris N, Kozielski A, et al. Alkyl esters of camptothecin and 9-nitrocamptothecin: synthesis, in vitro pharmacokinetics, toxicity, and antitumor activity [ J]. J Med Chem, 1998,41( 1 ) :31 -37.
  • 8Scott DO, Bindra DS, Stella VJ. Plasma pharmacokinetics of the lactone and carboxylate forms of 20 ( S ) -camptothecin in anesthetized rats [ J ]. Pharm Res, 1993,10(10) :1451 - 1457.
  • 9Chow DS, Gong L, Wolfe MD, et al. Modified lactone/carboxylate salt equilibrium in vivo by liposomal delivery of 9-nitrocamptothecin [ J]. Ann NY Acad Sci, 2000,922:164 - 174.
  • 10Li YF, Zhang RW. Reversed-phase high performance liquid chromatography method for the simultaneous quantitation of the lactone and carboxylate forms of the novel natural product anticancer agent 10-hydroxycamptothecin in biological fluids and tissues [ J ].J Chromatogr B, 1996,686:257 - 265.

共引文献24

同被引文献1988

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部